Mesa Laboratories Inc (MLAB) Stock Price
MLABStock
$122.48+65.18%52W
Market Cap$685.38M
P/E102.11x
PEG Ratio11.24
Div yield0.70%
Beta1.09
MLAB Share Price Chart
Favorite Metrics
Price vs S&P 500 (26W)13.85%
Price vs S&P 500 (4W)-5.80%
PEG Ratio11.24
VGM Score57.16
P/E Ratio (Annual)102.11x
Indicated Dividend Yield (Annual)0.70%
MLAB Earnings Surprise History
| Quarter | Report date | EPS estimate | EPS actual | Surprise |
|---|---|---|---|---|
| Q2 2026 | $2.55 | $1.30 | -49.13%(-$1.25) | |
| Q1 2026 | $1.39 | $1.83 | +31.47%(+$0.44) | |
| Q4 2025 | $1.47 | $1.76 | +19.94%(+$0.29) | |
| Q3 2025 | $1.56 | $2.11 | +35.15%(+$0.55) | |
| Q2 2025 | $2.16 | $1.88 | -12.91%(-$0.28) |
MLAB Analyst Recommendations
Jun 2026
Jul 2026
Aug 2026
Sep 2026
4.00
4.00
4.00
4.00
Industry Peers — Industrial Instruments(16)
| Symbol | Value Score | Growth Score | Momentum Score | P/S Ratio (TTM) | Revenue Growth (5Y) | Gross Margin (TTM) | Operating Margin (TTM) | Price |
|---|---|---|---|---|---|---|---|---|
MLABMesa Laboratories Inc | C | D | A | 2.7x | 13.2% | 64.2% | 9.0% | $122.48 |
| DHRDanaher Corporation | D | C | B | 6.4x | 2.0% | 58.6% | 20.4% | $229.04 |
| AMEAmetek, Inc. | D | C | B | 7.2x | 10.3% | 36.9% | 25.6% | $248.17 |
| KEYSKeysight Technologies, Inc. | D | B | B | 8.6x | 5.0% | 64.7% | 20.3% | $331.21 |
| ROPRoper Technologies, Inc. Common Stock | C | B | B | 4.6x | 14.5% | 69.5% | 28.0% | $382.71 |
| FTVFortive Corporation | C | D | B | 4.0x | -2.1% | 63.2% | 18.2% | $57.79 |
| MKSIMKS Inc. Common Stock | C | B | C | 3.3x | 11.0% | 47.0% | 15.4% | $214.83 |
| CGNXCognex Corp | D | C | C | 8.3x | 4.2% | 68.9% | 21.8% | $53.99 |
| RALRalliant Corporation | C | C | B | 3.4x | — | 50.9% | -53.3% | $66.55 |
| STSensata Technologies Holding plc | B | D | B | 1.6x | 4.0% | 29.5% | 7.6% | $40.58 |
| SENSSenseonics Holdings, Inc. Common Stock | D | A | B | 8.5x | 48.1% | 54.9% | -223.2% | $7.77 |
About Mesa Laboratories Inc
Mesa Laboratories manufactures specialized quality control and life sciences tools serving the sterilization, pharmaceutical, and genomics markets. Its portfolio spans sterilization and disinfection indicators, genetic analysis systems, automated protein analysis platforms, and calibration solutions. The company provides critical quality assurance products across biopharmaceutical development, clinical diagnostics, and industrial sterilization processes.